Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Trends in Molecular Medicine|June 3, 2026
Under pressure: peroxisomes in cancer therapy resistanceNicla Lorito, Francesca Bonechi, Elisabetta Romano, et al.Molecular and Cellular Biochemistry|May 23, 2025
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.Cell Death & Disease|January 31, 2025
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic diseaseAlfredo Smiriglia, Nicla Lorito, Marina Bacci, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 22, 2026
Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot studyFrancesco La Torre, Eleonora Nardi, Francesca Bonechi, et al.EMBO Molecular Medicine|June 26, 2024
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancerNicla Lorito, Angela Subbiani, Alfredo Smiriglia, et al.Cancer Research|November 7, 2025
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast CancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.Science Translational Medicine|February 28, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancerMarina Bacci, Nicla Lorito, Alfredo Smiriglia, et al.Science Advances|September 17, 2025
Linear ubiquitination prevents lipodystrophy and obesity-associated metabolic syndromeXimena Hildebrandt, Önay Veli, Armel Hyoubi, et al.Pageof 1